Alect2 amyloidosis: primum non nocere (first, do no harm) Maria M. Picken Kidney International Volume 86, Issue 2, Pages 229-232 (August 2014) DOI: 10.1038/ki.2014.45 Copyright © 2014 International Society of Nephrology Terms and Conditions
Figure 1 A simplified scheme for the evaluation of amyloidoses in nephro-urology. AA, amyloidosis derived from serum amyloid A protein; AL, amyloidosis derived from immunoglobulin light chain; Alect2, amyloidosis derived from leukocyte chemotactic factor 2; ASCT, autologous stem-cell transplantation; IFE, immunofixation electrophoresis; sFLCh, serum free light chain assay; TNF, tumor necrosis factor. Kidney International 2014 86, 229-232DOI: (10.1038/ki.2014.45) Copyright © 2014 International Society of Nephrology Terms and Conditions